4 Mr. Shatter asked the Minister for Health and Children the extent of the risk of patients contracting new variant CJD from blood products supplied by the Blood Transfusion Service Board; whether all red blood cells will be filtered in order to eliminate the possibility of BSE related agents getting into blood products; the steps, if any, he is taking to ensure that the medical profession is vigilant in identifying possible cases of new variant CJD; and whether he intends to sanction additional consultative posts in virology and infectious diseases for the Blood Transfusion Service Board. [20018/97]

Summary

4 Mr. Shatter asked the Minister for Health and Children the extent of the risk of patients contracting new variant CJD from blood products supplied by the Blood Transfusion Service Board; whether all red blood cells will be filtered in order to eliminate the possibility of BSE related agents getting into blood products; the steps, if any, he is taking to ensure that the medical profession is vigilant in identifying possible cases of new variant CJD; and whether he intends to sanction additional consultative posts in virology and infectious diseases for the Blood Transfusion Service Board. [20018/97]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Ceisteanna — Questions. Priority Questions. - CJD in Blood Products.

  xml · EN · 20 November 1997

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.